Abstract
Prolonged survival of patients with Marfan syndrome after aortic root replacement has led to an increased number of patients with aortic complications beyond the root. Elective replacement of the aortic root removes the most important predilection site for aneurysms, but the distal aorta remains at risk. Predictors for aortic growth and adverse events in the distal aorta include aortic diameter, aortic distensiblity, previous aortic root replacement, hypertension and aortic regurgitation. After aortic dissection, the initial false lumen diameter is an independent predictor for late aneurysm formation. Although there are a few reports of short-term success after endovascular stent grafting of the descending thoracic aorta, stent grafting in patients with Marfan syndrome is not recommended unless intervention is clearly indicated and the risk of conventional open surgical repair is deemed prohibitive. Optimal long-term outcome demands lifelong radiographic follow-up and medical treatment with β-blocker therapy. After aortic dissection rigorous antihypertensive medication is of utmost importance. Losartan, an angiotensin II type I receptor antagonist, might offer the first potential for primary prevention of clinical manifestations in Marfan syndrome, but the results of clinical trials have to be awaited. (Neth Heart J 2008;16:382-6.)
Similar content being viewed by others
References
Therrien J, Gatzoulis M, Graham T, Bink-Boelkens M, Connelly M, Niwa K, et al. CCS Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease – Part II. Can J Cardiol 2001 ;17:1029-50.
Nollen GJ, Groenink M, Van der Wall EE, Mulder BJM. Marfan syndrome: Current insights in diagnosis and management of cardiovascular complications. Cardiol Young 2002;12:320-7.
Nollen GJ, Mulder BJM. What's new in Marfan syndrome? Int J Cardiol 2004;97(suppl 1):103-8.
Groenink M, Lohuis TAJ, Tijssen JPG, Naeff MSJ, Hennekam RCM, Van der Wall EE, et al. Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart 1999;82:499-504.
Engelfriet PM, Tijssen JGP, Kaemmerer H, Gatzoulis MA, Boersma E, Oechslin E, et al. Adherence to guidelines in the clinical care for adults with congenital heart disease. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2006; 27:737-45.
Meijboom LJ, Groenink M, Van der Wall EE, Romkes H, Stoker J, Mulder BJM. Aortic root asymmetry in Marfan patients; evaluation by magnetic resonance imaging and comparison with standard echocardiography. Int J Cardiac Imag 2000;16:161-8.
Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilén U, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005;26:2325-3.
Carrel T, Beyeler L, Schnyder A, Zurmuhle P, Berdat P, Schmidli J, et al. Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery. Eur J Cariothorac Surg 2004;25: 671-5.
Van der Velde ET, Vriend JWJ, Mannens MMAM, Uiterwaal CSPM, Brand R, Mulder BJM. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results. Eur J Epidemiol 2005;20:549-57.
Halloran BG, Davis VA, McManus BM, Lynch TG, Baxter BT. Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 1995;59:17-22.
Engelfriet PM, Boersma E, Tijssen JGP, Bouma BJ, Mulder BJM. Beyond the root: dilatation of the distal aorta in the Marfan's syndrome. Heart 2006;92:1238-3.
Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewics DM. Marfan syndrome. Long term survival and complications after aortic aneurysm repair. Circulation 1995;91:728-33.
Nollen GJ, Groenink M, Tijssen JGP, Van der Wall EE, Mulder BJM. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J 2004;25: 1146-52.
Nollen GJ, Meijboom LJ, Groenink M, Timmermans J, Barentsz JO, Merchant N, et al. Comparison of aortic elasticity in patients with the Marfan syndrome with and without aortic root replacement. Am J Cardiol 2003;91:637-40.
Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJM. Aortic root growth in men and women with the Marfan's syndrome. Am J Cardiol 2005;96:1441-4.
Groenink M, Rozendaal L, NaeffMSJ, Hennekam RCM, Hart AAM, Van der Wall EE, et al. Diagnostic and prognostic value of aortic root growth in children and adolescents with Marfan syndrome. Heart 1998;80:163-9.
Rozendaal L, Groenink M, NaeffMSJ, Hennekam RCM, Hart AAM, Van der Wall EE, et al. Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilation. Heart 1998;79:69-72.
Van Karnebeek CDM, NaeffMSJ, Mulder BJM, Hennekam ECM, Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001 ;84:129-37.
Oosterhof T, Groenink M, Hulsmans F, Van der Wall EE, Hennekam RCM, Smit R, et al. Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology 2001;220:514-8.
Nollen GJ, Van Schijndel KE, Timmermans J, Groenink M, Barentsz JO, Van der Wall EE, et al. Pulmonary artery root dilatation in Marfan syndrome: Quantitative assessment of an unknown criterion. Heart 2002;87:470-1.
Lazarevic AM, Nakatani S, Okita Y, Marinkovic J, Takeda Y, Hirooka K, et al. Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome. Int J Cardiol 2006;106:177-82.
Legget ME, Unger TA, O'Sullivan CK, Zwink TR, Bennett RL, Byers PH, et al. Aortic root complications in Marfan's syndrome : identification of a lower risk group. Heart 1996;75:389-95.
Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJM. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914-20.
Song JM, Kim SD, Kim JH, Kim MJ, Kang DH, Seo JB, et al. Long- term predictors of descending aorta aneurismal change in patients with aortic dissection. J Am Coll Cardiol 2007;50:799-804.
Doroghazi RM, Slater EE, DeSanctis RW, Buckley MJ, Austen WG, Rosenthal S. Long term survival of patients with treated aortic dissection. J Am Coll Cardiol 1984;3:1026-34.
Zierer A, Voeller RK, Hill KE, Kouchoukos NT, Damiano RJ, Moon MR. Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg 2007;84:479-87.
Svensson LG, Kouchoukos NT, Craig Miller D, Bavaria JE, Coselli, JS, Curi MA, et al. Wheatley III Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts. Ann Thorac Surg 2008; 85(suppl):S1-41.
Coselli JS, LeMaire SA. Current status of thoracoabdominal aortic aneurysm repair in Marfan syndrome. J Card Surg 1997;12:167-72.
Meijboom LJ, Westerhof BE, Nollen GJ, Spaan JAE, De Mol BAJM, Jacobs MJHM, et al. Beta-blocking therapy in patients with Marfan syndrome and entire aortic replacement. Eur J Cardio Thor surg 2004;26:901-6.
Engelfriet P, Mulder BJM. Is there benefit of β-blocking agents in the treatment of patients with the Marfan syndrome? Int J Cardiol 2007;114:300-2.
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-21.
Matt P, Habashi J, Carrel T, Cameron DE, Van Eyk JE, Dietz HC. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg 2008;135:389-94.
Aalberts JJ, van den Berg MP, Bergman JE, du Marchie Sarvaas GJ, Post JG, van Unen H, et al. The many faces of aggressive aortic pathology: Loeys-Dietz syndrome. Neth Heart J2008;16:299-304.
Symersky P, Vriend JWJ, Spijkerboer AM, Mulder BJM, Legemate DA, De Mol BAJM. Endovascular treatment of a bleeding aortic aneurysm after descending aortic aneurysm repair with island re-implantation. J Thorac Cardiovasc Surg 2005;130:576-7.
Vriend JWJ, Meijboom LJ, Nollen GJ, Jonkers RE, De Mol BAJM, Mulder BJM. Compression of the left main bronchus and pulmonary artery after entire aortic replacement with dacron arterial grafts. Ann Thorac Surg 2004;78:E54-E55.
Author information
Authors and Affiliations
Corresponding author
Additional information
Department of Cardiology, Academic Medical Center Amsterdam, the Netherlands
Correspondence to: B.J.M. Mulder Department of Cardiology, Academic Medical Center, PO Box 226600, 1100 DD Amsterdam, the Netherlands
Rights and permissions
About this article
Cite this article
Mulder, B.J.M. The distal aorta in the Marfan syndrome. NHJL 16, 382–386 (2008). https://doi.org/10.1007/BF03086183
Issue Date:
DOI: https://doi.org/10.1007/BF03086183